133 related articles for article (PubMed ID: 26215676)
1. A contrasting function for miR-137 in embryonic mammogenesis and adult breast carcinogenesis.
Lee JM; Cho KW; Kim EJ; Tang Q; Kim KS; Tickle C; Jung HS
Oncotarget; 2015 Sep; 6(26):22048-59. PubMed ID: 26215676
[TBL] [Abstract][Full Text] [Related]
2. Expression of miR-206 during the initiation of mammary gland development.
Lee MJ; Yoon KS; Cho KW; Kim KS; Jung HS
Cell Tissue Res; 2013 Sep; 353(3):425-33. PubMed ID: 23733266
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation.
Zuo J; Yu Y; Zhu M; Jing W; Yu M; Chai H; Liang C; Tu J
Cancer Biomark; 2018 Feb; 21(2):383-392. PubMed ID: 29103027
[TBL] [Abstract][Full Text] [Related]
4. Role of microRNA221 in regulating normal mammary epithelial hierarchy and breast cancer stem-like cells.
Ke J; Zhao Z; Hong SH; Bai S; He Z; Malik F; Xu J; Zhou L; Chen W; Martin-Trevino R; Wu X; Lan P; Yi Y; Ginestier C; Ibarra I; Shang L; McDermott S; Luther T; Clouthier SG; Wicha MS; Liu S
Oncotarget; 2015 Feb; 6(6):3709-21. PubMed ID: 25686829
[TBL] [Abstract][Full Text] [Related]
5. miR-200-containing extracellular vesicles promote breast cancer cell metastasis.
Le MT; Hamar P; Guo C; Basar E; Perdigão-Henriques R; Balaj L; Lieberman J
J Clin Invest; 2014 Dec; 124(12):5109-28. PubMed ID: 25401471
[TBL] [Abstract][Full Text] [Related]
6. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
[TBL] [Abstract][Full Text] [Related]
7. The caM kinase, Pnck, is spatially and temporally regulated during murine mammary gland development and may identify an epithelial cell subtype involved in breast cancer.
Gardner HP; Ha SI; Reynolds C; Chodosh LA
Cancer Res; 2000 Oct; 60(19):5571-7. PubMed ID: 11034105
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.
Aydoğdu E; Katchy A; Tsouko E; Lin CY; Haldosén LA; Helguero L; Williams C
Carcinogenesis; 2012 Aug; 33(8):1502-11. PubMed ID: 22562546
[TBL] [Abstract][Full Text] [Related]
9. Mammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis.
Saeki K; Chang G; Kanaya N; Wu X; Wang J; Bernal L; Ha D; Neuhausen SL; Chen S
Commun Biol; 2021 Jun; 4(1):660. PubMed ID: 34079055
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA in the ovine mammary gland during early pregnancy: spatial and temporal expression of miR-21, miR-205, and miR-200.
Galio L; Droineau S; Yeboah P; Boudiaf H; Bouet S; Truchet S; Devinoy E
Physiol Genomics; 2013 Feb; 45(4):151-61. PubMed ID: 23269700
[TBL] [Abstract][Full Text] [Related]
11. Influence of normal mammary epithelium on breast cancer progression: the protective role of early pregnancy.
Martins FC; Botelho MF; Cabrita AM; de Oliveira CF
Tumori; 2010; 96(6):999-1003. PubMed ID: 21388065
[TBL] [Abstract][Full Text] [Related]
12. TRAIL-induced miR-146a expression suppresses CXCR4-mediated human breast cancer migration.
Wang D; Liu D; Gao J; Liu M; Liu S; Jiang M; Liu Y; Zheng D
FEBS J; 2013 Jul; 280(14):3340-53. PubMed ID: 23647548
[TBL] [Abstract][Full Text] [Related]
13. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
[TBL] [Abstract][Full Text] [Related]
14. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
Wang N; Zhou Y; Zheng L; Li H
Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
16. Development of microRNA-145 for therapeutic application in breast cancer.
Kim SJ; Oh JS; Shin JY; Lee KD; Sung KW; Nam SJ; Chun KH
J Control Release; 2011 Nov; 155(3):427-34. PubMed ID: 21723890
[TBL] [Abstract][Full Text] [Related]
17. miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo.
Savi F; Forno I; Faversani A; Luciani A; Caldiera S; Gatti S; Foa P; Ricca D; Bulfamante G; Vaira V; Bosari S
Clin Sci (Lond); 2014 Aug; 127(4):233-42. PubMed ID: 24527800
[TBL] [Abstract][Full Text] [Related]
18. microRNA alterations in ALDH positive mammary epithelial cells: a crucial contributing factor towards breast cancer risk reduction in case of early pregnancy.
Nandy SB; Subramani R; Rajamanickam V; Lopez-Valdez R; Arumugam A; Boopalan T; Lakshmanaswamy R
BMC Cancer; 2014 Aug; 14():644. PubMed ID: 25176219
[TBL] [Abstract][Full Text] [Related]
19. [microRNA expression in breast development and breast cancer].
Avril S
Pathologe; 2013 Nov; 34 Suppl 2():195-200. PubMed ID: 24196612
[TBL] [Abstract][Full Text] [Related]
20. Differentially methylated microRNAs in prediagnostic samples of subjects who developed breast cancer in the European Prospective Investigation into Nutrition and Cancer (EPIC-Italy) cohort.
Cordero F; Ferrero G; Polidoro S; Fiorito G; Campanella G; Sacerdote C; Mattiello A; Masala G; Agnoli C; Frasca G; Panico S; Palli D; Krogh V; Tumino R; Vineis P; Naccarati A
Carcinogenesis; 2015 Oct; 36(10):1144-53. PubMed ID: 26168820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
